
    
      A placebo-controlled, double blind study of zinc supplementation in imipramine therapy was
      conducted in sixty, depressed patients fulfilling the DSM-IV criteria for major depression
      without psychotic symptoms. After a one week washout period, patients were randomized into
      two groups treated with imipramine and receiving once daily either placebo (n=30) or zinc
      supplementation (n=30) for 12 weeks.
    
  